Rosuvastatin Completed Phase 2 Trials for End-Stage Kidney Disease / Arteriovenous Fistulas / Diabetes Mellitus (DM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01863914Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula
NCT00296374Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease